End-to-End Platform: Creative Biolabs to Participate in the 6th Exosome Therapeutic Summit

From September 17 to 19, 2024, the 6th Exosome-Based Therapeutic Development Summit will bring together global experts in the field of exosome-based therapeutics. Among the key participants is Creative Biolabs, a leading force in exosome research and development.

The summit, hosted at the Hilton Boston Logan Airport Hotel, will focus on cutting-edge advancements in exosome analysis, characterization, purification, and clinical applications. Creative Biolabs, renowned for its innovative approaches, is set to make a substantial impact at this event.

“The development of exosome-based therapeutics still faces numerous challenges, particularly in the clinical translation. Effective technical support and optimization are essential at various stages, including exosome production, purification, quality control, and drug delivery,” said a representative from Creative Biolabs.

As a global leader in the life sciences, Creative Biolabs offers a comprehensive suite of services tailored to the needs of exosome-based therapeutic research and development. At this summit, the company will showcase its latest innovations in exosome characterization, purification, cargo loading, and antibody development.

Exosome Antibody Development: This service targets antibodies specific to exosome surface markers. “We use phage display antibody screening and B cell sorting for exosomes to efficiently identify antibodies with high sensitivity and specificity for exosome-related antigens.”

Exosome Characterization: Employing high-precision analytical methods, Creative Biolabs offers comprehensive exosome characterization, including morphology, size, surface markers, and content analysis. Techniques such as nanoparticle tracking analysis, transmission electron microscopy, fluorescence-activated cell sorting, Western blotting, ELISA, and TRPS are utilized to support further research.

Exosome Purification Technology: Creative Biolabs has developed a range of efficient purification methods, including ultracentrifugation, density gradient centrifugation, size-exclusion chromatography, and affinity chromatography. These methods enable the large-scale preparation of high-purity exosomes, with the most suitable technique selected based on the sample’s characteristics and research goals.

Exosome Cargo Loading: Creative Biolabs offers advanced methods for loading exogenous substances into exosomes, facilitating their use in drug delivery and gene therapy. The company employs two primary strategies:

* Post-Loading: This strategy involves introducing specific drugs or genetic material into exosomes after their formation, allowing for targeted regulation of exosome functions. Methods such as electroporation, liposome transfection, sonication, and calcium chloride treatment are typically employed.

* Pre-Loading: This approach involves loading exogenous materials into the parent cells, which are then incorporated into the exosomes. By leveraging the cell’s natural secretion mechanism, this method ensures that exosomes carry the desired therapeutic substances from the moment they are formed.

Creative Biolabs also offers solutions for the transportation and storage of exosome reference standards, utilizing lyophilization technology to ensure stable storage at 4°C for up to 36 months. These high-quality lyophilized exosome reference standards are ideal for applications such as FACS, Western blotting, ELISA, and exosome quantification calibration, sourced from a variety of biological samples to meet diverse research needs.

For more information on exosome services and products, visit https://www.creative-biolabs.com/exosome/.

About Creative Biolabs

Creative Biolabs is a global leader in providing technical services for research in the life sciences, with a strong focus on exosome-based therapeutic development. The expert team from Creative Biolabs will engage with attendees at the summit, sharing their latest innovations and solutions in the field of exosomes. The company looks forward to connecting with industry peers in Boston.

Leave a Reply

Your email address will not be published. Required fields are marked *

*